The Lin-Zhi International, Inc. (LZI) Benzodiazepine (BZO) Enzyme Immunoassay is intended for the qualitative and semi-quantitative determination of benzodiazepines in human urine at a cutoff value of 200 ng/mL or 300 ng/mL
The assay is designed for prescription use with a number of automated clinical chemistry analyzers
The LZI Benzodiazepine assay is a homogeneous enzyme immunoassay ready-to-use liquid reagent
